Myriad Genetics (MYGN) Shares Skyrocket, What You Need To Know [Yahoo! Finance]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Yahoo! Finance
CEO, Samraat Raha, purchased a significant amount of company stock. According to filings, Raha bought 40,000 shares for a total of approximately $200,000, at an average price near $5.00 per share. This purchase increased his direct ownership to 493,104 shares. Such a large buy from a top executive is often viewed by investors as a strong vote of confidence in the company's future direction and value. The move was particularly notable given that reports indicated the company's shares had declined over the previous year. Is now the time to buy Myriad Genetics? Access our full analysis report here, it's free What Is The Market Telling Us Myriad Genetics's shares are extremely volatile and have had 46 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 7 days ago when the stock gained 5.9%
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- 3 Reasons to Sell MYGN and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc [Yahoo! Finance]Yahoo! Finance
- 2 Unprofitable Stocks on Our Buy List and 1 We Brush Off [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics (MYGN) Stock Trades Up, Here Is Why [Yahoo! Finance]Yahoo! Finance
MYGN
Earnings
- 2/23/26 - Beat
MYGN
Sec Filings
- 3/9/26 - Form 4
- 3/5/26 - Form EFFECT
- 3/4/26 - Form 424B3
- MYGN's page on the SEC website